What does DIC stand for in pregnancy?

Disseminated intravascular coagulation in pregnancy.

What test confirms DIC?

D-dimer is the better test for DIC. Accordingly, testing for D-dimer or FDPs may be helpful for differentiating DIC from other conditions that may be associated with a low platelet count and prolonged clotting times, such as chronic liver disease. Most laboratories have an operational test for D-dimer.

What is the most sensitive test for DIC?

Routinely performed tests for DIC such as platelet count and prothrombin time may be normal in chronic DIC. There is no single test that would diagnose DIC, however, estimation of D-dimer appears to be the most sensitive and specific test.

What triggers DIC in pregnancy?

Acute obstetrical hemorrhage is one of the leading causes for DIC in pregnancy and is one of the most avoidable etiologies of maternal death.

How do you treat DIC in pregnancy?

DIC must be managed by treating the underlying disease, which may require surgical and nonsurgical interventions, antibiotic therapy, replacement of blood products, fluid therapy and uterine evacuation. Supportive anticoagulant drugs are given to resolve coagulation abnormalities.

Is INR elevated in DIC?

Patients with DIC often have reduced levels of both clotting factors and also endogenous anticoagulant proteins. This may create a situation where patients appear to be hypocoagulable based on traditional labs (e.g., platelet count and INR) – but they are actually hypercoagulable.

What is a classic symptom of DIC?

Pain, redness, warmth, and swelling in the lower leg if blood clots form in the deep veins of your leg. Headaches, speech changes, paralysis (an inability to move), dizziness, and trouble speaking and understanding if blood clots form in the blood vessels in your brain. These signs and symptoms may indicate a stroke.

What labs are in DIC panel?

Panel includes Partial Thromboplastin Time (PTT), Prothrombin Time with INR (PT7), Fibrinogen (FIB), Advanced D-Dimer (ADV DIMER), and Platelet Count (PLT). A platelet count obtained within 24 hours of the DIC collection time may be used if no EDTA K2 specimen is submitted concurrently.

What can trigger DIC?

Causes

  • Blood transfusion reaction.
  • Cancer, especially certain types of leukemia.
  • Inflammation of the pancreas (pancreatitis)
  • Infection in the blood, especially by bacteria or fungus.
  • Liver disease.
  • Pregnancy complications (such as placenta that is left behind after delivery)
  • Recent surgery or anesthesia.

What is DIC after C section?

DIC causes blood clots to form in small blood vessels and can lead to serious bleeding. Certain pregnancy and childbirth complications (like placenta accreta), surgery, sepsis (blood infection) and cancer can cause DIC. Infection, like chorioamnionitis. This is an infection of the placenta and amniotic fluid.

How is DIC diagnosed and treated during pregnancy?

The diagnosis of DIC can be elusive during pregnancy and requires vigilance and knowledge of the physiologic changes during pregnancy. Pregnancy specific DIC scores and adjustment of the cutoff of point of care testing can facilitate the diagnosis and the management of DIC in pregnancy.

Can Pregnancy specific scoring system diagnose DIC in pregnant women?

The incorporation of pregnancy specific scoring system to diagnose DIC in pregnant women is an accurate and easy to use and may assist clinicians in real time during at the Labor and Delivery wards.

What is the most common pregnancy complication associated with DIC?

The proportions of the contribution of each risk factor varies among countries. Indeed, the most frequent pregnancy complication associated with DIC according to Rattray et al 4 was placental abruption followed by PPH and preeclampsia.

What is disseminated intravascular coagulation in pregnancy?

Disseminated intravascular coagulation in pregnancy. The DIC syndrome is the most common cause of an abnormal hemorrhage tendency during pregnancy and the puerperium and reflects systemic activation of the coagulation cascade by circulating thromboplastic material, with secondary activation of the fibrinolytic system.